Acquisition will further advance Teleflexâs Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices WAYNE, Pa., Feb. 27, 2025 ...
As a reminder, the board made its decision to transition the Chief Executive Officer position following the announced sale of ...
Teleflex Innovation S.A.R.L. (Teleflex) owns multiple patents to a dual catheter design, wherein an extension catheter is disposed within a larger guide catheter coaxially. This coaxial orientation ...
Teleflex TFX recently launched the Arrow EZ-IO Intraosseous Access Procedure Tray, which contains all the components required for the IO access procedure. The tray includes the first FDA-cleared ...
WAYNE, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has published its 2024 Global Impact Report. The ...
Teleflex Incorporated has announced its agreement to acquire most of the Vascular Intervention business from BIOTRONIK SE & Co. KG for approximately âĴ760 million, pending regulatory approvals and ...
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter 2025 financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 26, ...
Q4 2025 earnings call recap: divestitures, $1.8B proceeds, $1B buyback, 2026 EPS $6.25â$6.55, risks & outlookâread now.
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of ...
Tejara Capital Ltd disclosed a buy of 69,700 Teleflex (NYSE:TFX) shares in a February 5 SEC filing, with an estimated transaction value of $8.45 million based on quarterly average pricing. According ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results